Association of the Treatment Induced Clearance of Hepatitis C Virus Infection with the IL28B Gene Polymorphisms
Open Access
- 30 December 2015
- journal article
- Published by Peertechz Publications Private Limited in Archives of Hepatitis Research
- Vol. 1 (1), 005-008
- https://doi.org/10.17352/ahr.000002
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Interleukin 28B Gene Polymorphism and Association with Chronic Hepatitis C Therapy Results in LatviaHepatitis Research and Treatment, 2012
- Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much MoreClinical Infectious Diseases, 2011
- Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide PolymorphismsPLOS ONE, 2011
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapyNature Genetics, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistenceJCI Insight, 2009
- Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation KineticsGastroenterology, 2006
- Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytesJournal of Hepatology, 2006
- The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994The New England Journal of Medicine, 1999